Clinical TrialsSearch results
Number of results: 68528
Completed
- A phase 1 study of TAS3731 in Healthy Adults
- Healthy adult males
- Sato Atsushi
- 2022-12-12
Completed
- A phase 1 study of VLPCOV-01 in COVID-19 vaccinated healthy subjects
- Prevention of infectious disease caused by SARS-CoV-2
- Nobuaki Sato
- 2022-02-01
Completed
- A Phase 1 study to assess the safety, tolerability, and immunogenicity of VN-0200 after intramuscular injection in Japanese healthy adults and elderly subjects
- Prevention of respiratory syncytial virus
- Inoguchi Akihiro
- 2021-05-07
Completed
- A phase 1 trial of OPB-171775 in patients with advanced or metastatic malignant solid tumors
- advanced or metastatic malignant solid tumors
- Headquarters of Clinical Development
- 2020-11-18
Completed
- A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Axatilimab When Administered by Intravenous Infusion to Healthy Japanese Participants
- GVHD, healthy voluteer
- Ono Shintaro
- 2023-02-27
Completed
- A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB054707 When Administered Orally to Healthy Japanese Participants
- Inflammatory disease
- On Shintaro
- 2021-10-18
Completed
- A Phase 1, open label study to evaluate the pharmacokinetics, safety and tolerability of single subcutaneous dose amlitelimab in healthy adult participants.
- Healthy adult participants
- Tanaka Tomoyuki
- 2022-08-31
Completed
- A Phase 1, Open-Label, Single Dose Study to Evaluate the Pharmacokinetics (PK), Safety, and Tolerability of Epetraborole Tablets and the Impact of Alcohol Dehydrogenase (ADH) Genotype on the PK of Epetraborole and Metabolite M3 in Healthy Japanese Adult Subjects
- Mycobacterium avium complex (MAC) lung disease
- Kanmuri Kazuhiro
- 2022-04-22
Completed
- A Phase 1, single-dose and multiple-dose study of DS-2319b inhalation powder to assess the safety and pharmacokinetics of DS-2319a in healthy Japanese subjects
- SARS-CoV-2 Infectious Disease
- Inoguchi Akihiro
- 2021-03-12
Completed
- A Phase 1, Single-Dose, Multiple-Dose, Food Effect and Drug-Drug Interaction Study of BPN14770
- Health Condition
- Nagata Tsutae
- 2020-11-06